MOVe-NOW will build on existing LAGEVRIO data to assess efficacy in the current COVID-19 environment and support applications for licensure The MOVe-NOW study will use a different formulation of ...

The antiviral pill can be taken at home. More countries will have access to Merck & Co’s COVID-19 pill. The deal backed by the United Nations will allow nearly 30 drugmakers in Asia, Africa and the ...

The world could soon be armed with another tool to fight the coronavirus pandemic: a twice-daily pill that has been shown to reduce the risk of hospitalization and death among people infected with the ...

CNN — Merck said Monday it is seeking US Food and Drug Administration emergency use authorization for its experimental antiviral Covid-19 treatment, molnupiravir. If authorization is granted, the drug ...

Kenilworth-based Merck is asking the U.S. Food and Drug Administration for emergency approval of a COVID-19 antiviral pill after trials for the drug showed promising results, the company announced Oct ...

The FDA said Friday that Merck's anti-COVID-19 pill is effective in treating the virus but said that regulators will meet next week to investigate whether the pill is safe for people who are pregnant ...

Oct 26 (Reuters) - Merck & Co (MRK.N), opens new tab on Thursday reported higher-than-expected third-quarter results on surprisingly strong demand for its COVID-19 treatment, primarily in Japan, and ...

The first pill shown to treat COVID-19 has moved one step closer to being available to the public. The pharmaceutical company Merck requested FDA emergency authorization Monday for their COVID-19 ...

New Yorkers with COVID are eligible for free home deliveries of antiviral treatments, Mayor Adams said Sunday as he touted a continued decrease in case numbers. The city will provide same-day delivery ...

The U.S. government has agreed to purchase 1.4 million more courses of molnupiravir, Merck’s experimental COVID-19 antiviral drug, for roughly $1 billion, the drugmaker said Nov. 9. The deal is ...